Related Experiment Video
Updated: Jun 21, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Adipokines in liver diseases
Fabio Marra1, Cristiana Bertolani
1Department of Internal Medicine, University of Florence, Florence, Italy. f.marra@dmi.unifi.it
Adipokines, signaling molecules from fat tissue, influence liver health. Understanding their role in obesity and liver diseases like NAFLD and Hepatitis C is crucial for developing new treatments.
Area of Science:
- Endocrinology
- Hepatology
- Immunology
Background:
- Adipokines are signaling molecules produced by adipose tissue, including adipocytes, macrophages, and vascular stromal cells.
- Adipose tissue inflammation alters adipokine secretion patterns, impacting metabolic and hepatic health.
- Key adipokines include leptin, adiponectin, resistin, tumor necrosis factor, and interleukin-6.
Purpose of the Study:
- To investigate the role of adipokines in hepatic injury associated with fatty infiltration.
- To explore the correlation between plasma adiponectin levels and nonalcoholic fatty liver disease (NAFLD) severity, insulin resistance, and liver damage.
- To examine the potential link between adipokines, viral infections (Hepatitis C), steatosis, and metabolic disturbances.
Main Methods:
- Review of studies investigating plasma adiponectin levels in NAFLD patients.
- Analysis of adipokine involvement in modulating steatosis, inflammation, and fibrosis in liver injury.
- Exploration of adipokine roles in Hepatitis C pathogenesis and metabolic complications.
Main Results:
- Adipokines differentially modulate steatosis, inflammation, and fibrosis in fatty liver disease.
- Plasma adiponectin levels correlate with insulin resistance and the severity of liver damage in NAFLD.
- Adipokines may link viral infections, steatosis, and metabolic disturbances in Hepatitis C.
Conclusions:
- Adipokines play a significant role in the pathogenesis of liver diseases, including NAFLD and Hepatitis C.
- Identifying specific adipokines and their functions is critical for understanding obesity's impact on liver health.
- Targeting adipokines may offer novel therapeutic strategies for managing metabolic and liver diseases.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...

